• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者血清胎球蛋白B水平升高:一项病例对照研究。

Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study.

作者信息

Zhu Jinzhou, Wan Xingyong, Wang Yuming, Zhu Kefu, Li Chunxiao, Yu Chaohui, Li Youming

机构信息

Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang Province, China.

The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310003, Zhejiang Province, China.

出版信息

Endocrine. 2017 Apr;56(1):208-211. doi: 10.1007/s12020-016-1112-5. Epub 2016 Sep 14.

DOI:10.1007/s12020-016-1112-5
PMID:27628583
Abstract

Fetuin is an endogenous inhibitor of the insulin receptor tyrosine kinase. Recent studies supported the possible role of fetuin B in metabolic diseases. This study is to evaluate the role of serum fetuin B in nonalcoholic fatty liver disease (NAFLD). A hospital-based case-control study of 184 subjects was conducted. Serum level of fetuin B was measured by enzyme-linked immunosorbent assay. The serum level of fetuin B in the control (91.0 ± 36.9 μg/ml) was lower than it in NAFLD (108.7 ± 38.5 μg/ml, P < 0.001). The percentage of NAFLD increased (42.9%, 58.7% and 60.2%; P < 0.001; linear-by-linear association: P < 0.001), as fetuin B concentration elevated in its tertiles, after adjustment of body mass index (BMI). Furthermore, compared with the 1st tertile, the 3rd tertile of fetuin B indicated an association with the presence of NAFLD (adjusted odds ratio = 2.087, 95% confidence interval [1.016 - 3.937], P = 0.023), after controlling age, sex, BMI, diabetes, hypertension and hypertriglyceridemia. Lastly, fetuin B correlated with diastolic blood pressure, serum alanine transaminase and triglycerides, among the controls. It suggested a potential association between serum fetuin B and the presence of NAFLD.

摘要

胎球蛋白是胰岛素受体酪氨酸激酶的内源性抑制剂。最近的研究支持了胎球蛋白B在代谢性疾病中的可能作用。本研究旨在评估血清胎球蛋白B在非酒精性脂肪性肝病(NAFLD)中的作用。对184名受试者进行了一项基于医院的病例对照研究。采用酶联免疫吸附测定法检测血清胎球蛋白B水平。对照组血清胎球蛋白B水平(91.0±36.9μg/ml)低于非酒精性脂肪性肝病组(108.7±38.5μg/ml,P<0.001)。在调整体重指数(BMI)后,随着胎球蛋白B浓度在其三分位数中升高,非酒精性脂肪性肝病的百分比增加(42.9%、58.7%和60.2%;P<0.001;线性趋势检验:P<0.001)。此外,表示胎球蛋白B的第三个三分位数与非酒精性脂肪性肝病的存在相关(调整后的比值比=2.087,95%置信区间[1.016 - 3.937],P = 0.023),在控制年龄、性别、BMI、糖尿病、高血压和高甘油三酯血症之后。最后,在对照组中,胎球蛋白B与舒张压、血清丙氨酸转氨酶和甘油三酯相关。这表明血清胎球蛋白B与非酒精性脂肪性肝病的存在之间存在潜在关联。

相似文献

1
Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study.非酒精性脂肪性肝病患者血清胎球蛋白B水平升高:一项病例对照研究。
Endocrine. 2017 Apr;56(1):208-211. doi: 10.1007/s12020-016-1112-5. Epub 2016 Sep 14.
2
Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.胎球蛋白-B 通过诱导胰岛素抵抗将非酒精性脂肪性肝病与 2 型糖尿病联系起来:关联和路径分析。
Cytokine. 2018 Aug;108:145-150. doi: 10.1016/j.cyto.2018.03.023. Epub 2018 Mar 30.
3
Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.血清胎球蛋白-B 水平是 2 型糖尿病患者非酒精性脂肪肝的独立标志物。
Eur J Gastroenterol Hepatol. 2019 Jul;31(7):859-864. doi: 10.1097/MEG.0000000000001354.
4
Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study.胎球蛋白-B 将非酒精性脂肪肝疾病与肥胖中国成年人的慢性肾脏病联系起来:一项横断面研究。
Ann Nutr Metab. 2019;74(4):287-295. doi: 10.1159/000499843. Epub 2019 Apr 9.
5
Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.胎球蛋白 B 与非酒精性脂肪性肝病肝纤维化标志物的相关性。
Endocrine. 2017 Nov;58(2):246-252. doi: 10.1007/s12020-017-1417-z. Epub 2017 Sep 15.
6
Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.在伴有或不伴有非酒精性脂肪性肝病的糖耐量受损患者中,胎球蛋白-A 浓度升高,但空腹血糖受损患者则不然。
J Clin Endocrinol Metab. 2012 Dec;97(12):4717-23. doi: 10.1210/jc.2012-2414. Epub 2012 Oct 12.
7
Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross-sectional study.血清胎球蛋白-B 与肝内甘油三酯含量呈正相关,并增加肥胖中国成年人胰岛素抵抗的风险:一项横断面研究。
J Diabetes. 2018 Jul;10(7):581-588. doi: 10.1111/1753-0407.12632. Epub 2018 Jan 5.
8
Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.学龄儿童非酒精性脂肪性肝病的患病率、危险因素及预测因素:埃及亚历山大市一项基于医院的研究
Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.
9
Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.在接受选择性冠状动脉造影的患者中,血清胎球蛋白-A 水平与冠状动脉粥样硬化负担和非酒精性脂肪性肝病的关系。
Metab Syndr Relat Disord. 2013 Aug;11(4):289-95. doi: 10.1089/met.2012.0149. Epub 2013 Apr 19.
10
A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.素食不能预防非酒精性脂肪性肝病(NAFLD):佛教僧侣与普通人群的横断面研究
Turk J Gastroenterol. 2015 Jul;26(4):336-43. doi: 10.5152/tjg.2015.0046. Epub 2015 Jun 2.

引用本文的文献

1
Evaluation of the correlation between fetuin-B levels and essential hypertension: a cross-sectional study.胎球蛋白-B水平与原发性高血压之间的相关性评估:一项横断面研究。
Endocr Connect. 2023 Nov 8;12(12). doi: 10.1530/EC-23-0172. Print 2023 Dec 1.
2
Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota.乳酸杆菌和胞磷胆碱对脂肪性肝炎的有益作用:Nrf2/HO-1和肠道微生物群的作用
AMB Express. 2023 Jun 8;13(1):57. doi: 10.1186/s13568-023-01561-8.
3
Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis.

本文引用的文献

1
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.欧洲肝脏研究学会(EASL)-欧洲糖尿病研究学会(EASD)-欧洲肥胖症研究学会(EASO)非酒精性脂肪性肝病管理临床实践指南
Obes Facts. 2016;9(2):65-90. doi: 10.1159/000443344. Epub 2016 Apr 8.
2
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism.胎球蛋白 B 是一种分泌性肝细胞因子,将脂肪变性与葡萄糖代谢受损联系起来。
Cell Metab. 2015 Dec 1;22(6):1078-89. doi: 10.1016/j.cmet.2015.09.023. Epub 2015 Oct 22.
3
Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.
非酒精性脂肪性肝病和非酒精性脂肪性肝炎中肝分泌物、星状细胞分泌物、肌细胞分泌物和脂肪细胞分泌物的调控网络及相互作用。
Front Endocrinol (Lausanne). 2022 Sep 30;13:1007944. doi: 10.3389/fendo.2022.1007944. eCollection 2022.
4
Hepatokine Fetuin B expression is regulated by leptin-STAT3 signalling and associated with leptin in obesity.肝因子 B 的表达受瘦素-STAT3 信号通路调控,并与肥胖症中的瘦素相关联。
Sci Rep. 2022 Jul 27;12(1):12869. doi: 10.1038/s41598-022-17000-w.
5
Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach.基于串联质量标签的定量蛋白质组学方法对支架内再狭窄患者的血浆蛋白质组分析
Front Cardiovasc Med. 2022 Feb 21;9:793405. doi: 10.3389/fcvm.2022.793405. eCollection 2022.
6
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.肝源细胞因子与非酒精性脂肪性肝病:将肝脏病理生理学与代谢相联系
Biomedicines. 2021 Dec 14;9(12):1903. doi: 10.3390/biomedicines9121903.
7
Fetuin-B, a potential link of liver-adipose tissue cross talk during diet-induced weight loss-weight maintenance.胎球蛋白-B,饮食诱导体重减轻-维持期间肝脏-脂肪组织串扰的潜在联系。
Nutr Diabetes. 2021 Oct 5;11(1):31. doi: 10.1038/s41387-021-00174-z.
8
Hepatokine Pregnancy Zone Protein Governs the Diet-Induced Thermogenesis Through Activating Brown Adipose Tissue.肝分泌因子妊娠区带蛋白通过激活棕色脂肪组织来调控饮食诱导的产热。
Adv Sci (Weinh). 2021 Nov;8(21):e2101991. doi: 10.1002/advs.202101991. Epub 2021 Sep 13.
9
Elevated Circulating Fetuin-B Levels Are Associated with Insulin Resistance and Reduced by GLP-1RA in Newly Diagnosed PCOS Women.循环胎球蛋白 B 水平升高与胰岛素抵抗相关,并可被新诊断 PCOS 女性的 GLP-1RA 降低。
Mediators Inflamm. 2020 Sep 30;2020:2483435. doi: 10.1155/2020/2483435. eCollection 2020.
10
Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.非酒精性脂肪性肝病中胎球蛋白-A 和胎球蛋白-B:荟萃分析和荟萃回归。
Int J Environ Res Public Health. 2020 Apr 15;17(8):2735. doi: 10.3390/ijerph17082735.
血清骨膜蛋白是一种用于非酒精性脂肪性肝病的潜在生物标志物:一项病例对照研究。
Endocrine. 2016 Jan;51(1):91-100. doi: 10.1007/s12020-015-0735-2. Epub 2015 Sep 11.
4
Prevalence of Nonalcoholic Fatty Liver Disease and Economy.非酒精性脂肪性肝病的患病率与经济状况
Dig Dis Sci. 2015 Nov;60(11):3194-202. doi: 10.1007/s10620-015-3728-3. Epub 2015 May 28.
5
The serum protein fetuin-B is involved in the development of acute myocardial infarction.血清蛋白胎球蛋白-B参与急性心肌梗死的发展过程。
Clin Sci (Lond). 2015 Jul;129(1):27-38. doi: 10.1042/CS20140462.
6
[Diagnosis and treatment of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的诊断与治疗
Zhonghua Gan Zang Bing Za Zhi. 2014 Sep;22(9):705-7.
7
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans.循环中的胎球蛋白-A与游离脂肪酸相互作用,以预测人类的胰岛素抵抗。
Nat Med. 2013 Apr;19(4):394-5. doi: 10.1038/nm.3116.
8
Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats.饮食诱导肥胖易感和肥胖抵抗大鼠的血浆蛋白质组分析。
Proteomics. 2010 Dec;10(24):4386-400. doi: 10.1002/pmic.201000391. Epub 2010 Nov 17.
9
Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein.3型胱抑素;胎球蛋白、激肽原和富含组氨酸的糖蛋白。
Front Biosci (Landmark Ed). 2009 Jan 1;14(8):2911-22. doi: 10.2741/3422.
10
Plasma fetuin-A levels and the risk of type 2 diabetes.血浆胎球蛋白-A水平与2型糖尿病风险
Diabetes. 2008 Oct;57(10):2762-7. doi: 10.2337/db08-0538. Epub 2008 Jul 15.